Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysis
Abstract Background Cancer cachexia affects more than half of all cancer patients, reducing survival rates. Evidence‐based approaches are urgently needed to optimize treatment. Methods A systematic review and network meta‐analysis were conducted to assess the effectiveness and safety of different ph...
Saved in:
Main Authors: | Hao Chen, Masashi Ishihara, Hiroki Kazahari, Ryusuke Ochiai, Shigeru Tanzawa, Takeshi Honda, Yasuko Ichikawa, Nobuyuki Horita, Hisashi Nagai, Kiyotaka Watanabe, Nobuhiko Seki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70166 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sarcopenia as a leading component of malignant cachexia syndrome
by: V. K. Lyadov, et al.
Published: (2012-02-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01) -
The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
by: Andrew C. Kidd, et al.
Published: (2024-01-01) -
Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01) -
2020–2021 Florida Citrus Production Guide: Exocortis, Cachexia, and Other Viroids
by: Amit Levy, et al.
Published: (2020-08-01)